SPARC and breast carcinoma: For example, breast cancer patients with high tumor SPARC expression were seriously more sensitive to an albumin-bound paclitaxel 22, potentially because of the strong binding capacity of SPARC to albumin, which could lead to the accumulation of paclitaxel in local tumor microenvironment.